Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.97
-0.20 (-2.18%)
At close: Jul 17, 2026, 4:00 PM EDT
9.00
+0.03 (0.33%)
After-hours: Jul 17, 2026, 7:47 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 325 employees as of December 31, 2025. The number of employees increased by 51 or 18.61% compared to the previous year.
Employees
325
Change (1Y)
51
Growth (1Y)
18.61%
Revenue / Employee
$160,117
Profits / Employee
-$893,840
Market Cap
1.96B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 325 | 51 | 18.61% |
| Dec 31, 2024 | 274 | 7 | 2.62% |
| Dec 31, 2023 | 267 | -7 | -2.55% |
| Dec 31, 2022 | 274 | 46 | 20.18% |
| Dec 31, 2021 | 228 | 47 | 25.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Lakefront Biotherapeutics NV | 558 |
| Nuvation Bio | 307 |
| Syndax Pharmaceuticals | 298 |
| UroGen Pharma | 298 |
| Viridian Therapeutics | 252 |
| Monte Rosa Therapeutics | 187 |
| Aurinia Pharmaceuticals | 128 |
OCUL News
- 9 days ago - Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences - GlobeNewsWire
- 4 weeks ago - Ocular Therapeutix price target raised to $25 from $21 at H.C. Wainwright - TheFly
- 4 weeks ago - Ocular Therapeutix price target raised to $30 from $24 at Baird - TheFly
- 4 weeks ago - Ocular Therapeutix Transcript: Investor Day 2026 - Transcripts
- 4 weeks ago - Ocular Therapeutix Press release: FY 2026 - Filings
- 4 weeks ago - Ocular Therapeutix Slides: FY 2026 - Filings
- 4 weeks ago - Ocular Therapeutix trading resumes - TheFly